Roivant Sciences Ltd. (ROIV) Social Stream



Roivant Sciences Ltd. (ROIV): $9.71

-0.04 (-0.41%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add ROIV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#290 of 381

in industry

ROIVANT SCIENCES LTD (ROIV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ROIV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 6 $15 $10 $12.2 $9.09 34.21%
2021-12-22 6 $16 $11 $13.4 $9.09 47.41%
2022-02-15 6 $16 $11 $14 $9.09 54.02%
2022-05-13 7 $16 $11 $14.2 $9.09 56.22%
2022-05-22 7 $16 $3.7 $12.45 $9.09 36.96%
2022-05-23 8 $16 $6 $12.833 $9.09 41.18%
2022-05-26 8 $16 $6 $12.714 $9.09 39.87%
2022-08-16 8 $16 $7 $12.571 $9.09 38.29%
2022-09-28 8 $15 $6 $11 $9.09 21.01%
2022-10-27 8 $15 $6 $10.5 $9.09 15.51%
2022-11-02 7 $15 $7 $10.75 $9.09 18.26%
2022-11-15 8 $15 $7 $10.75 $9.09 18.26%
2022-12-12 9 $19 $8 $12 $9.09 32.01%
2022-12-19 9 $19 $8 $12.25 $9.09 34.76%
2022-12-27 9 $19 $9 $12.75 $9.09 40.26%
2023-01-05 9 $19 $9 $13.125 $9.09 44.39%
2023-02-14 9 $19 $10 $13.25 $9.09 45.76%
2023-03-16 9 $19 $10 $13.375 $9.09 47.14%
2023-03-17 9 $19 $10 $13.5 $9.09 48.51%
2023-05-18 8 $19 $10 $13.875 $9.09 52.64%

The Trend in the Analyst Price Target


ROIV's average price target has moved up $2.88 over the prior 33 weeks.

Over the past 45 weeks, ROIV's average upside potential has been 97.03%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-02 7 15 7 10.750 5.11 110.37%
2022-11-15 9 15 7 10.750 5.54 94.04%
2023-01-05 9 19 9 13.125 8.14 61.24%
2023-03-16 9 19 10 13.375 8.50 57.35%
2023-05-18 8 19 10 13.875 9.09 52.64%

ROIV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 8 0 0 0 0 8

The Trend in the Broker Recommendations


Over the past 35 weeks, ROIV's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ROIVANT SCIENCES LTD's average analyst price target is higher than 416.49% of them.
  • To contextualize these metrics, consider that out of all US stocks, ROIVANT SCIENCES LTD's variance in analysts' estimates is lower than -1881.9% of them.
  • In terms of how ROIVANT SCIENCES LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 702.43% of that group.
  • In terms of how ROIVANT SCIENCES LTD fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 1453.33% of that group.

Stocks similar to ROIVANT SCIENCES LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PRAX, AVIR, and LMDX.

Make investment decisions regarding ROIV using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.753 seconds.